Clinical Assessment and Genetic Characterization of Spinocerebellar Ataxias

Spinocerebellar ataxias (SCAs) comprise a diverse group of inherited neurodegenerative disorders defined by progressive loss of motor coordination, cerebellar dysfunction and, in many subtypes, extracerebellar features such as neuropathy or oculomotor deficits. Clinical assessment integrates structured rating scales, notably the Scale for the Assessment and Rating of Ataxia (SARA), quantitative gait and balance measures, speech analysis and imaging biomarkers. Recent advances in molecular genetics have transformed diagnostic workflows, enabling detection of pathogenic repeat expansions and point mutations via short‐read and long‐read sequencing platforms. Comprehensive genotype–phenotype correlation has revealed thresholds for repeat length, sequence interruptions and flanking haplotypes that modulate disease onset and penetrance. These insights support personalised diagnostic strategies, inform natural history studies and underpin the development of targeted therapies, from gene silencing to small‐molecule modulators of protein aggregation.

Research from Nature Portfolio

New genomic analyses have refined the understanding of repeat expansion disorders underlying adult‐onset cerebellar ataxia. High‐throughput detection algorithms applied to short‐read genome data accurately identify expansions in fibroblast growth factor 14 (FGF14), the locus responsible for SCA27B. By integrating long‐range PCR and nanopore sequencing in large patient and control cohorts, investigators have delineated pathogenic repeat thresholds at a lower boundary of 180–200 uninterrupted AAG units and distinguished them from benign hexameric configurations. Sequence interruptions and distinct 5′ flanking motifs correlate with expansion size and variant secondary structures. Clinically, pure AAG repeats present with episodic ataxia and downbeat nystagmus, establishing SCA27B as a major contributor to previously unsolved adult‐onset ataxia cases and prompting revision of molecular diagnostic criteria.

Clinical Assessment and Genetic Characterization of Spinocerebellar Ataxias publication trend

The graph below shows the total number of articles in clinical assessment and genetic characterization of spinocerebellar ataxias across all publications each year (not limited to Nature Index journals).

Technical terms

Ataxia: A clinical syndrome of impaired coordination, gait disturbance and balance dysfunction resulting from cerebellar or related pathway involvement.

Short tandem repeat (STR) expansion: A mutation in which consecutive DNA motifs are abnormally amplified, often disrupting gene expression or protein function.

Pentanucleotide expansion: A subclass of STRs consisting of five-nucleotide repeat units whose pathological enlargement can cause neurological disease.

Nanopore sequencing: A long-read DNA sequencing method that detects nucleotide sequences by monitoring ionic current changes as DNA strands pass through a nanopore, enabling direct resolution of complex repeats.

Scale for the Assessment and Rating of Ataxia (SARA): A clinician‐administered scale quantifying ataxia severity across gait, posture, limb coordination and speech domains.

References

1. SARAspeech—Feasibility of automated assessment of ataxic speech disturbance. npj Digital Medicine (2023).
2. Identification and characterisation of pathogenic and non-pathogenic FGF14 repeat expansions. Nature Communications (2024).
3. L-arginine in patients with spinocerebellar ataxia type 6: a multicentre, randomised, double-blind, placebo-controlled, phase 2 trial. EClinicalMedicine (2024).
4. RFC1 expansions are a common cause of idiopathic sensory neuropathy. Brain (2021).